Genomics News and Research

RSS

Genomics is the study of the complete genetic material, including genes and their functions, of an organism.

Sanford-Burnham, Takeda partner to develop new therapeutic targets for cardiovascular disease

Sanford-Burnham Medical Research Institute at Lake Nona today announced it has signed a two-year partnership agreement with Takeda Pharmaceutical Company Ltd. of Japan to study the potential role of several gene regulatory proteins as targets for the treatment of heart failure.

29 May 2015

Proteomics research market estimated to reach $1.6 billion this year

Pharmaceutical companies and diagnostics companies spend billions developing new drugs and tests, and this is translating into a sizeable market for the instruments that can assist them. This according to Kalorama Information, a healthcare market research publisher. Kalorama Information said instruments such as mass spectrometry, electrophoresis and liquid chromatography that can assist in the identification of drug targets and the validation of biomarkers, are in demand.

29 May 2015

ACMG unveils new online educational portal focusing on genetics and genomic medicine

The American College of Medical Genetics and Genomics has unveiled its new ACMG Genetics Academy for Genetic and Genomic Education at www.acmg.net/education, an online educational portal where healthcare professionals interested in genetics and genomics in clinical and laboratory practice can enroll in courses and create their own personal learning management center.

28 May 2015

ClearDATA closes $25 million Series C funding round

ClearDATA announced today the close of an over-subscribed $25 million Series C funding round with contributions from Heritage Group, HLM Venture Partners and Flare Capital Partners, along with existing investors Norwest Venture Partners, Merck Global Health Innovation Fund and Excel Venture Management.

28 May 2015

Researchers identify chemical pathway associated with seizures, shorter survival in patients with malignant glioma

Researchers at the University of Alabama at Birmingham have identified a chemical pathway that may be associated with seizures and shorter patient survival in some patients with malignant glioma, the most common and deadly form of brain tumor. In findings published May 27 in Science Translational Medicine, the researchers suggest that a transporter known as SXC is responsible for boosting levels of glutamate in the brains of some glioma patients.

28 May 2015

EKF Diagnostics highlighting cancer molecular diagnostics products at ASCO 2015

EKF subsidiary, Selah Genomics’ newly introduced PrecisionPath™ next generation sequencing (NGS) technology cancer test will be a key focus on Booth #19141...

From EKF Diagnostics 28 May 2015

Researchers use animal models to study how dysfunction of genes contributes to ASD risk

Autism Spectrum Disorder (ASD) is a neurological condition that affects approximately two percent of people around the world. Although several genes have been linked to multiple concurring conditions of ASD, the process that explains how specific genetic variants lead to behaviors characteristic of the disorder remains elusive.

27 May 2015

Researchers present new program to evaluate clinical relevance of genetic variants

Millions of genetic variants have been discovered over the last 25 years, but interpreting the clinical impact of the differences in a person's genome remains a major bottleneck in genomic medicine. In a paper published in The New England Journal of Medicine on May 27, a consortium including investigators from Brigham and Women's Hospital and Partners HealthCare present ClinGen, a program to evaluate the clinical relevance of genetic variants for use in precision medicine and research.

27 May 2015

Individually rare CNVs may be negatively associated with educational attainment

Individually rare but collectively common intermediate-size copy number variations may be negatively associated with educational attainment, according to a study in the May 26 issue of JAMA. Copy number variations (CNVs) are regions of the genome that differ in the number of segments of DNA.

27 May 2015

Clinical utility data for Guardant360 platform to be presented at ASCO 2015

Guardant Health today announced that five abstracts submitted by the University of California, San Francisco; University of California, San Diego; and MD Anderson highlighting the performance and clinical utility of Guardant360 have been accepted for oral and poster presentations at the 2015 American Society of Clinical Oncology Annual Meeting in Chicago, May 29-June 2.

27 May 2015

Liverpool scientists complete genomics studies on multidrug resistant Typhoid fever in Africa

The team has completed two genomics studies on the tropical disease, a condition that is estimated to cause up to 30 million illnesses and over a quarter of a million deaths globally each year.

27 May 2015

TGen professor to receive top award from Arizona Medical Association

Dr. Daniel D. Von Hoff, Distinguished Professor and Physician-In-Chief of the Translational Genomics Research Institute, will receive one of the top awards May 29 from the Arizona Medical Association.

24 May 2015

Esophageal cancer patients treated with proton therapy experience less toxic side effects

New research by scientists at the University of Maryland School of Medicine has found that esophageal cancer patients treated with proton therapy experienced significantly less toxic side effects than patients treated with older radiation therapies.

24 May 2015

Clinical genomic sequencing could impact treatment decisions in advanced prostate cancer patients

An international collaboration of researchers are advancing precision medicine to men with advanced prostate cancer.

22 May 2015

TGen and Baylor partnership set to increase treatment options for cancer patients

The Translational Genomics Research Institute (TGen) and Baylor Research Institute (BRI) at Dallas today announce an agreement that will focus on accelerating early detection and treatments for patients with a broad range of cancers.

22 May 2015

Splicing pattern of obesity, type 2 diabetes genes may contribute to pathophysiology of obesity

Alternative splicing of obesity and type 2 diabetes related genes may contribute to the pathophysiology of obesity, according to research from the University of Eastern Finland. Obesity leads to changes in the splicing pattern of metabolically relevant genes such as TCF7L2 and INSR, resulting in impaired insulin action.

22 May 2015

Industry leaders meet at Frost & Sullivan's GIL 2015: Europe in London to learn, share new strategies for innovation

Between 2012 and 2014, over 70 companies globally valued at more than $1 billion were start-ups with new business models that were unique and transformative. During the same period, most business model innovators have managed to produce consistently profitable returns with average revenue gain between 100 and 500 percent. The keys to these success stories have been connectivity and convergence with 50 percent of new start-ups launched on mobile platforms.

22 May 2015

Scientists reveal how lymphatic system develops in embryo

For over one hundred years, scientists have debated the question of the origins of the lymphatic system - a parallel system to the blood vessels that serves as a conduit for everything from immune cells to fat molecules to cancer cells. This issue has now been resolved by Dr. Karina Yaniv of Weizmann Institute's Biological Regulation Department. In a study reported online today in Nature, she and her team revealed how the lymphatic system develops in the embryo and for the first time managed to grow lymphatic cells in the lab.

21 May 2015

Celgene to use Cypher's Coral technology to find novel genomic biomarkers

Cypher Genomics, Inc., a leading genome informatics company, today announced a collaboration with Celgene Corporation to apply Cypher's Coral technology to discover novel genomic biomarkers that associate with patient response to innovative medicines.

20 May 2015

Corus CAD test can help clinicians rule-out low-risk patients from additional cardiac testing

CardioDx, Inc., a molecular diagnostics company specializing in cardiovascular genomics, announced today results from a multi-center, community-based patient registry, the PRESET Registry, evaluating the use of the Corus CAD test in patients with symptoms suggestive of obstructive coronary artery disease (CAD) in the primary care setting.

20 May 2015

Genomics News and Research

Further Reading

Sanford-Burnham, Takeda partner to develop new therapeutic targets for cardiovascular disease

Proteomics research market estimated to reach $1.6 billion this year

ACMG unveils new online educational portal focusing on genetics and genomic medicine

ClearDATA closes $25 million Series C funding round

Researchers identify chemical pathway associated with seizures, shorter survival in patients with malignant glioma

EKF Diagnostics highlighting cancer molecular diagnostics products at ASCO 2015

Researchers use animal models to study how dysfunction of genes contributes to ASD risk

Researchers present new program to evaluate clinical relevance of genetic variants

Individually rare CNVs may be negatively associated with educational attainment

Clinical utility data for Guardant360 platform to be presented at ASCO 2015

Liverpool scientists complete genomics studies on multidrug resistant Typhoid fever in Africa

TGen professor to receive top award from Arizona Medical Association

Esophageal cancer patients treated with proton therapy experience less toxic side effects

Clinical genomic sequencing could impact treatment decisions in advanced prostate cancer patients

TGen and Baylor partnership set to increase treatment options for cancer patients

Splicing pattern of obesity, type 2 diabetes genes may contribute to pathophysiology of obesity

Industry leaders meet at Frost & Sullivan's GIL 2015: Europe in London to learn, share new strategies for innovation

Scientists reveal how lymphatic system develops in embryo

Celgene to use Cypher's Coral technology to find novel genomic biomarkers

Corus CAD test can help clinicians rule-out low-risk patients from additional cardiac testing

Industry focus eBook: Genomics (4th edition) eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo